Back to Search
Start Over
Keymed Biosciences Announced Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM
- Source :
- Plus Company Updates. June 24, 2024
- Publication Year :
- 2024
-
Abstract
- CHENGDU: Keymed Biosciences Inc. (HKEX: 02162) announced that Lei Zhang/Renchi Yang's team from the Institute of Hematology, Chinese Academy of Medical Sciences has recently published a research paper entitled A [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.800430315